Pharmacokinetics of Patisiran, the First Approved RNA Interference Therapy in Patients With Hereditary Transthyretin‐Mediated Amyloidosis
出版年份 2019 全文链接
标题
Pharmacokinetics of Patisiran, the First Approved RNA Interference Therapy in Patients With Hereditary Transthyretin‐Mediated Amyloidosis
作者
关键词
-
出版物
JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-11-28
DOI
10.1002/jcph.1553
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Advances in the treatment of hereditary transthyretin amyloidosis: A review
- (2019) Morie A. Gertz et al. Brain and Behavior
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
- (2018) Merrill D. Benson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipid Nanoparticle Systems for Enabling Gene Therapies
- (2017) Pieter R. Cullis et al. MOLECULAR THERAPY
- Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe
- (2016) Yesim Parman et al. CURRENT OPINION IN NEUROLOGY
- “Red-flag” symptom clusters in transthyretin familial amyloid polyneuropathy
- (2016) Isabel Conceição et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Hereditary ATTR amyloidosis: a single-institution experience with 266 patients
- (2015) Paul L. Swiecicki et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Evolving landscape in the management of transthyretin amyloidosis
- (2015) Philip N. Hawkins et al. ANNALS OF MEDICINE
- Cardiac Findings and Events Observed in an Open-Label Clinical Trial of Tafamidis in Patients with non-Val30Met and non-Val122Ile Hereditary Transthyretin Amyloidosis
- (2015) Thibaud Damy et al. Journal of Cardiovascular Translational Research
- Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs
- (2014) Adam Castaño et al. HEART FAILURE REVIEWS
- Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling
- (2013) Gaurav Sahay et al. NATURE BIOTECHNOLOGY
- Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis
- (2013) Teresa Coelho et al. NEW ENGLAND JOURNAL OF MEDICINE
- Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles
- (2013) Barbara L Mui et al. Molecular Therapy-Nucleic Acids
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo
- (2012) Muthusamy Jayaraman et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Transthyretin (TTR) Cardiac Amyloidosis
- (2012) Frederick L. Ruberg et al. CIRCULATION
- Lipid Nanoparticles Containing siRNA Synthesized by Microfluidic Mixing Exhibit an Electron-Dense Nanostructured Core
- (2012) Alex K. K. Leung et al. Journal of Physical Chemistry C
- Transthyretin Cardiac Amyloidoses in Older North Americans
- (2012) Kumar Dharmarajan et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Amyloid Neuropathies
- (2012) Susan C. Shin et al. MOUNT SINAI JOURNAL OF MEDICINE
- Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant
- (2011) P. T. Sattianayagam et al. EUROPEAN HEART JOURNAL
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
- (2010) Akin Akinc et al. MOLECULAR THERAPY
- Rational design of cationic lipids for siRNA delivery
- (2010) Sean C Semple et al. NATURE BIOTECHNOLOGY
- Exploratory assessment of dose proportionality: review of current approaches and proposal for a practical criterion
- (2008) Jürgen Hummel et al. PHARMACEUTICAL STATISTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now